PeptideStack
5.2kquestions
20kanswers
220users

How do I distinguish drug-attributable fatigue from an energy deficit?

Asked 23 Feb 2025Modified 13 months agoViewed 20k times
7

No other medication changes, no dietary changes, nothing else obviously confounding.

I noticed this today and I have not touched anything since, in case the state is diagnostic.

I have not discarded anything yet, so a test is still possible if that is the recommendation.

Should I be treating this as a failure or as noise?

fatigue
fatigue

Tiredness on treatment: how much is energy deficit, how much is dehydration or electrolyte drift, how much is genuinely drug-attributable, and…

78 questions
electrolytes
electrolytes

Sodium, potassium and magnesium during reduced intake and GI losses: what the symptoms of a shortfall look like, when a panel is worth drawing,…

72 questions
nutrition
nutrition

Eating on a suppressed appetite: hitting nutritional targets inside a small energy budget, micronutrient risk, meal structure, and what the trial…

100 questions
shareeditfollowflag
BA
askedben_akintola10k1623 Feb 2025
Worth saying whether you are keeping fluids down, because that changes the answer. – j_wierzbicki 8 months ago
How severe, and does anything relieve it? Both matter for what people will say. – Dr_Sara_Kuusela 7 months ago
add a comment

5 Answers

Accepted answer first, then by votes
-2

Accepted answer

This is the complaint with the widest differential and the one most often attributed too quickly.

Carbohydrate intake specifically affects training performance and perceived energy at a given total intake, which is why very low carbohydrate approaches feel worse in the gym at matched energy.

Gastrointestinal adverse events, indicative pooled rates

EventActive armPlacebo armTiming
Nausea40–45 %15–20 %Peaks 1–2 wk after each step
Vomiting15–25 %5–8 %Follows nausea
Diarrhoea20–30 %10–15 %Early, variable
Constipation20–25 %8–12 %Later onset, persistent
Discontinuation for GI events4–7 %1–2 %Mostly during escalation

Ranges span agents and doses; read the specific prescribing information for a specific figure.

Specifically, iron deficiency is common, particularly in menstruating women, and low intake plus a reduced red-meat share makes it more likely. Ferritin is the test, and it is an acute-phase reactant so it needs interpreting alongside CRP.

Ferritin as an acute-phase reactant is a recognised limitation and is why it is interpreted alongside an inflammatory marker.

If it persists at an adequate intake, get bloods rather than more theories.

shareimprove this answerflag
SL
answered · acceptedsian_llewellyn65k14718 Jun 2025
Any published figure for how long the constipation persists, given it does not attenuate? – v_ramaswamy 6 months ago
8I would add a sentence about when to stop managing it and start seeing someone. – marta_okonkwo 4 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
20

If it persists at an adequate intake, it needs blood work rather than more speculation.

A deficit beyond about a thousand kilocalories a day reliably produces fatigue, reduced training performance and reduced spontaneous movement. With appetite suppressed, deficits of that size arrive by accident rather than by plan.

Sleep quality often changes during rapid weight loss in both directions, and sleep debt produces fatigue that no amount of dietary adjustment will fix.

Sleep restriction produces measurable decrements in subjective energy and in training performance independently of energy intake.

Nothing here is medical advice.

Sleep is a variable here too, and no amount of eating fixes sleep debt.

shareimprove this answerflag
SL
answeredsian_llewellyn65k1471 Mar 2025
Thank you — this is the answer I was looking for. – plate_count_9k 3 months ago
add a comment
17

Start with the actual intake, because a substantially suppressed appetite produces deficits far larger than intended and fatigue is the first symptom.

Three days of honest weighed intake usually settles this. Estimated intake in this situation is systematically wrong and usually wrong in the direction that hides the problem.

It helps to be literal here: fatigue that appeared abruptly, rather than gradually with the deficit, is a different pattern and points away from intake.

Self-reported intake underestimates measured intake by twenty per cent or more in doubly labelled water comparisons.

Research-use compounds are not approved for human use.

Check fluid and sodium before anything more exotic.

edited 22 Mar 2025 by rhian_prydderch — added a caveat about sampling

shareimprove this answerflag
RP
answeredrhian_prydderch23k2712 Mar 2025
7Adding a vote because this deserves more of them. – jonas_ekstrom 5 days ago
6This should be linked from the help pages. – ines_brandt 8 months ago
add a comment
13

The underlying point is that dehydration and low sodium intake produce fatigue that is indistinguishable subjectively and much easier to fix.

Hypothyroidism, sleep apnoea, depression and anaemia all present as fatigue and all become more likely rather than less in this population, so attribution to the compound should be a diagnosis of exclusion.

Energy deficits above roughly a thousand kilocalories a day are associated with measurable reductions in resting metabolic rate, spontaneous activity and subjective energy in controlled studies.

Weigh three days of intake honestly. That answers this most of the time.

edited 21 Apr 2025 by cal_hennessy — corrected a unit error in the worked example

shareimprove this answerflag
CH
answeredcal_hennessy17k2723 Mar 2025
13

The short version: check intake, check hydration, check iron and thyroid if it persists, and only then attribute it to the compound.

Dehydration from reduced fluid intake alongside reduced food intake produces headache, lethargy and postural dizziness, and is the cheapest thing on the list to correct.

The pooled gastrointestinal adverse-event rates across the STEP programme and the SURMOUNT programme are reported in the primary publications and in the FDA and EMA assessment reports, and the assessment reports are more useful because they give the placebo-arm rates alongside the active-arm rates in the same table.

Abrupt onset points away from the deficit and towards something else.

shareimprove this answerflag
TI
answeredteodora_ilic17k275 May 2025
5This is the first explanation of the timing pattern that has actually made sense to me. – forty_two_c 5 months ago
4The red-flag list should be higher up the answer, not at the bottom. – tandem_gradient 4 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.